All UK & Rest of Europe articles – Page 55
-
NewsTuberculosis vulnerability of people with HIV: a viral protein implicated
Tuberculosis accounts for one in three deaths among people living with HIV. A new study highlights the key role played by Tat 2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon.
-
NewsPlant-derived compound has antimicrobial and anti-inflammatory effects against periodontal disease
Morin-based powder, extracted from guava leaves, apple peel, and figs, can be slowly released with the help of polymers and serve as an alternative to antibiotics.
-
NewsSpecial lactic acids reduce antibiotic resistance in infants
Researchers document that a special subgroup of naturally occurring bifidobacteria plays a crucial role in reducing antibiotic resistance in infants.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsStudy recommends integrated risk assessment for zoonotic and vector-borne diseases
A summary of published studies on the risk of emerging diseases shows that only 7.4% simultaneously consider hazard, exposure, and vulnerability to infection.
-
NewsCoral reefs set to stop growing as climate warms, scientists warn
Most coral reefs will soon stop growing and may begin to erode – and almost all will do so if global warming hits 2°C, according to a new study in the western Atlantic.
-
NewsHow HIV enters the genome – researchers identify previously unknown mechanism
Researchers have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids (R-loops) as molecular signposts for the virus.
-
NewsMicrobiotica announces completion of recruitment in its international phase 1b trial of microbiome co-therapy
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its advanced melanoma (MELODY-1) trial.
-
NewsBout of cystitis may signal presence of urogenital cancers in middle-aged adults
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle aged adults, suggests research. The risks seem to be especially high within 3 months of infection.
-
NewsCan microbes be the good guys? New study reveals Hollywood’s blind spot
A new review shows how films — from French Kiss to The Martian — highlight microbes as allies in food, medicine, and even space exploration.
-
NewsMediterranean diet could reduce gum disease, study shows
People living in the UK and following a diet close to the Mediterranean diet are more likely to have better gum health, with potentially lower amounts of gum disease and inflammation. A new study suggests that people not following a Mediterranean-style diet tended to have more severe gum disease, especially if they consumed red meat frequently.
-
NewsResearch identifies immune response that controls Oropouche infection and prevents neurological damage
Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.
-
NewsCholera kills more people for second consecutive year, while prevention and treatment available
The World Health Organization (WHO) has published its global cholera statistics for 2024, showing an increase in both the number of people who fell sick and died from the disease. Reported cholera cases rose by 5% and deaths by 50% in 2024 compared to 2023.
-
NewsMedications leave lasting mark on the gut microbiome, even years after use
Analysing stool samples and prescription records from over 2,500 Estonian Biobank participants, researchers found that the majority of drugs studied were linked to microbiome changes, with a substantial number of them also showing long-term effects detectable years after patients stopped taking them.
-
NewsMicrobial allies: Bacteria help fight against cancer
An international team of scientists have discovered that microbes associated with tumours produce a molecule that can control cancer progression and boost the effectiveness of chemotherapy.
-
NewsUS COVID-19 school closures were not cost-effective - but other non-pharmaceutical interventions were
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research analysing non-pharmaceutical interventions in the United States.
-
NewsAcross eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases
New research finds that municipalities in the Amazon region closest to healthy forests on Indigenous lands face less risk from rising cases of two categories of disease: cardiovascular and respiratory diseases due to forest fires and illnesses.
-
NewsIt’s not hopeless: Scientists want to learn lessons from climate change communication to save our soil
Soil scientists have urged us all to play our part in protecting our soil and to heed the lessons learnt from those who have been championing actions to mitigate the effects of climate change.
-
NewsMolecular Sustainable Solutions receives investment from BeAble Capital to boost disinfection and sterilization methods
Molecular Sustainable Solutions, a spin-off from the Universitat Jaume I of Castelló (UJI), secures €186,000 investment from BeAble Capital, a leading Science Equity fund specializing in disruptive scientific technologies.
-
NewsSwitching disease on and off: How a gene switch could help against bacterial infections
Researchers show how bacteria actively switch off their disease-causing mechanisms at high cell density and evade the immune system – a potential key to fighting infections better.